Live Breaking News & Updates on Saraca Laboratories Ltd

Stay updated with breaking news from Saraca laboratories ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Roll-Out of Manufacturing Incentives in India's Pharmaceuticals Sector

Foreign investors should note that PLI schemes are fast becoming the preferred vehicle for India's incentives to boost local manufacturing capacity creation. ....

Aurobindo Pharma , Sudarshan Pharma Industries , Optimus Drugs Private , Natural Biogenex Private , Symbiotec Pharmalab Pvt Ltd , Optimus Drugs Pvt Ltd , Symbiotech Pharmalab Private , Department Of Pharmaceuticals , Macleods Pharmaceuticals , Saraca Laboratories Ltd , Karnataka Antibiotics Pharmaceuticals , Hindys Lab Private , Aarti Specialty Chemicals , Natural Biogenex Pvt Ltd , Aartispeciality Chemicals Ltd , Hindys Lab Pvt Ltd , Macleods Pharmaceutical Ltd , Sudarshanpharma Industries Ltd , Emmennar Pharma Private , Saraca Laboratories , Emmennarpharma Pvt Ltd , Optimus Drugs Pvt , Biogenex Private Limited , Pharmalab Private Limited , Pharmaceuticals Limited , Drugs Private Limited ,

Atmanirbhar Pharma Sector: Govt Clears 19 Applications With Committed Investment Of Rs 4,623 Crore Under PLI Scheme

Atmanirbhar Pharma Sector: Govt Clears 19 Applications With Committed Investment Of Rs 4,623 Crore Under PLI Scheme
Prime Minister Narendra Modi with Finance Minister Nirmala Sitharaman.
With an objective to attain self-reliance and reduce import dependence in India s pharmaceutical sector, the government has cleared 19 applications with a committed investment of Rs 4,623.01 crore under its ambitious production linked incentive (PLI) scheme for the promotion of domestic manufacturing of critical key drug intermediates and active pharmaceutical ingredients (APIs), reports
Economic Times.
The development comes as the Department of Pharmaceuticals had launched a PLI Scheme for promotion of their domestic manufacturing by setting up greenfield plants with minimum domestic value addition in four different Target Segments two in fermentation based with at least 90 per cent and two in Chemical Synthesis based with at least 70 per cent - with a total outlay of Rs. 6,940 ....

Natural Biogenex Pvt Ltd , Symbiotec Pharmalab Pvt Ltd , Aartispeciality Chemicals Ltd , Hindys Lab Pvt Ltd , Optimus Drugs Pvt Ltd , Department Of Pharmaceuticals , Macleods Pharmaceutical Ltd , Sudarshanpharma Industries Ltd , Sadhana Nitro Chem Ltd , Saraca Laboratories Ltd , Emmennarpharma Pvt Ltd , Chemical Synthesis , Optimus Drugs Pvt , Sadhana Nitro Chem , Target Segment , Active Pharmaceutical Ingredient Api , Aatmanirbhar Bharat , Pharmaceutical Sector , Key Drugs , உகந்த மருந்துகள் பிரைவேட் லிமிடெட் , துறை ஆஃப் மருந்துகள் , மக்லாட்ஸ் மருந்து லிமிடெட் , சாதனா நைட்ரோ செம் லிமிடெட் , இரசாயன தொகுப்பு , உகந்த மருந்துகள் பிரைவேட் , சாதனா நைட்ரோ செம் ,

PLI scheme: Government approves 19 applications for domestic manufacturing of APIs, key drug intermediates

PLI scheme: Government approves 19 applications for domestic manufacturing of APIs, key drug intermediates
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Natural Biogenex Pvt Ltd , Symbiotec Pharmalab Pvt Ltd , Aartispeciality Chemicals Ltd , Hindys Lab Pvt Ltd , Optimus Drugs Pvt Ltd , Department Of Pharmaceuticals , Macleods Pharmaceutical Ltd , Sudarshanpharma Industries Ltd , Saraca Laboratories Ltd , Emmennarpharma Pvt Ltd , உகந்த மருந்துகள் பிரைவேட் லிமிடெட் , துறை ஆஃப் மருந்துகள் , மக்லாட்ஸ் மருந்து லிமிடெட் ,